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Parathyroidectomy (PTX) after renal transplantation (RT). M. N.
Chaabouni, J. Bedrossian, F. Metivier, P. Bourquelof, B. Veillon, and
A. Ulmann, Service de Nephrologie, Hôpital Broussais, Paris, France.
Seventeen PTX were performed in hypercalcemic renal transplant
recipients. Patients were 36 7 years old and had been hemodialyzed
for an average of 47 months. Asymptomatic hypercalcemia (HC) (2.65
0.08mmoles/liter) with hypophosphatemia (0.71 0.02 mmoles/liter)
was discovered a few months after RT. Measured values of PTH and
urinary cyclic AMP in seven patients were high, while Tm phosphate
was low. Steroid therapy in all patients was 0.52 0.21 mg/kg/day. PTX
was performed for persistent HC present for 3.5 to 98 months associ-
ated with hypercalciuria (9.1 1.8 mmoles/24 hr) in eight cases. PTX
(subtotal in ten and total in seven) was followed by a fall in serum
calcium (P < 0.001) and a rise in phosphate (P < 0.001). Patients were
divided into two groups, A and B, according to outcome. In group A,
six patients with NRF became hypocalcemic (2.03 0.08 mmoles/liter)
after PTX. Replacement therapy for I to 6 years corrected only three of
the cases of HC. Phosphate levels were 1.08 0.20 mmoles/liter PTH
was low in three patients and high in one because of hypercalciuria.
Group B included 11 patients: post-PTX calcium decreased to normal
levels (2.37 0.02 mmoles/liter) in six cases and to subnormal levels
(2.53 0.06 mmoles/liter) in five cases. One year later, only two
patients remained hypercalcemic. Phosphate levels were lower (0.83
0.18 mmoles/liter). Four patients have normal PTH levels and two have
low Tm phosphate. Among 17 parathyroidectomized patients, six
became hypocalcemic, two remained hypercalcemic, and only nine
were normocalcemic. No criteria were identified that could predict
course. The fact that post-RT HC is usually transient and that there is
a risk of permanent post-PTX hypocalcemia leads us to the conclusion
that P'FX may be hazardous and should be performed only in a limited
number of carefully chosen cases.
Gentamicin induces an increase of calcium, magnesium, phosphorus,
and N-acetyI-3-D-glucosamlnidase activity in rat urine. B. Olier, H.
Toutain, G. Viotte, J. P. Morin, J. P. Fillastre, and M. Godin. Groupe
de Physiopatholgie Tissulaire, University of Rouen, Rouen, France.
Female Wistar rats were treated once daily for 7 days with gentamicin
50 mg/kg. Rats were housed in diuresis cages during the treatment.
D-2-lN=l0 D2N=lO D5N=l0
D7N=l0
Diuresis, ml/24 hr 7.60 4.34 22.10* 21.70*
cAMP/creatinine,l0 1.37 0.95* 0.61* 0.42*
Ca/creatinine, 10 0.29 0.34 2.95* 2.66*
Pi/creatinine, IO 6.54 7.13 13.61* 6.48
NAG/creatinine,
U/mM 0.62 0.52 5.65* 7.63*
Mg/creatinine, I0- 0.69 1.21 2.15* 1.12
cAMP/calcium, 1O 6.59 3.97 0.29* 0.17*
Creatinine
clearance 0.98 0.89 0.37* 0.25*
Mitochondrial state3 160.10 — 87.50w
Diuresis, urinary cyclic AMP, urinary calcium, urinary phosphorus,
urinary magnesium, urinary N-acetyl-f3-D-glucosaminidase activity,
and urinary creatinine were valued after 24-hr periods. Mitochondrial
oxidative phosphorylation of renal cortex was assessed with succinate.
(See table.) Magnesium and phosphorus urinary excretion were little
increased. Calcium urinary increase was very high despite the creati-
nine clearance decrease. Urinary cyclic AMP was strongly decreased.
Urinary N-acetyl-/3-D-glucosaminidase activity increases with plasma
creatinine. The cyclic AMP/calcium ratio shows a significant decrease
at day 2 and fluctuates on a very wide scale. These ratio variations may
be of clinical value for early diagnosis of aminoglycoside-induced acute
renal failure.
Quick isolation of milligrams of medullary thick ascending limb from
rat kidney. Characterization of the tubules by adenylate cyclase sensitivity
to peptidic hormone. M.-M. Trinh-Trang-Tan, C. Coutaud, and L.
Bankir. INSERM U 90, Département de Nephrologie, Hôpiial Necker,
Paris, France. Apart from the microdissection technique, the methods
described previously for obtaining medullary thick ascending limbs of
Henle's loop (MTAL) in vitro are based on a complete dissociation of
kidney or outer medullary tissue in isolated cells by a long enzymatic
digestion followed by the separation of the different cell types on
sucrose, Percoll, or Ficoll gradients and subsequent washings. These
techniques have a poor yield and are time consuming. We have
designed a technique that allows fast preparation of relatively large
amounts of MTAL segments from rat kidney. It takes advantage of the
following points: I) MTAL make up about 60 to 70% of the epithelial
tissue in the inner stripe of the outer medulla; 2) MTAL has a much
stronger mechanical resistance than other nephron segments. After a
brief enzymatic digestion (collagenase 0.025%, 15 mm at 37°C), it forms
much longer segments than the other structures present in the inner
stripe. MTAL are isolated and rinsed on appropriate nylon sieves,
avoiding time-consuming centrifugations and resuspensions which
break the tubules and decrease the yield. These steps are carried out in
an oxygenated Hanks solution pH 7.4. Bovine serum albumin (1%) is
added to the final suspension. Tubules collected from the last sieve
(opening 100 gm), consist nearly exclusively of long pieces of MTAL.
One to 2 mg of MTAL can be obtained from the two kidneys of a 200 to
300 g rat in less than 2 hrs. Basal oxygen consumption of this MTAL
suspension, measured with a Clark electrode, is 50.7 2.4 l 02/mg
protein per hr. Furosemide 104M and ouabain l03M inhibit this
consumption by 67 and 47%, respectively. The adenylate cyclase (AC)
B
AVP
ase 10 M Glucagon10 M
N 7 7 7
AC activity 0.28 0.03 4.10 1.08 4.30 1.02
Hormone/base x 15.5 x 16.3
Calcitonin
lOOng/ml
PTH
2.l07M
N 5 4
AC activity 2.56 0.82 0.44 0.17
Hormone/base x8.7 xl.6
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activity of these tubules suspension is, in pmoles/g protein per 30 mm:
This technique allows in vitro biochemical and metabolical studies on
highly purified MTAL without the need to use microtechniques. It is
quick, has a high yield, and maintains the polarity of the epithelial cells.
Drinking water-induced plumbism in an anuric hemodialysis patient:
Treatment by hemofiltration and chelation. M. Kessler, P. Y. Durand,
E. Kaminski, J. Louis, T. Cao Huu, M. J. Royer-Moreau, M. Duc,
Service de Néphrologie, Laboratoire de Pharmacologie, Faculté de
Médecine, and Service de Médecine Générale "J", CHU de Brabois,
Vandoeuvre, France. Plumbism was diagnosed in April, 1984, in an
anuric woman 65 years of age, whose hemodialysis had begun 9 years
previously. Lead poisoning was completely cured by repeated
hemofiltration with calcium EDTA. This exceptional observation al-
lowed a nearly experimental study of the kinetics and metabolism of Ca
EDTA-chelated lead. 28.2 mg of lead were extracted during 26
hemofiltration sessions. After the twentieth session, the rate of ex-
tracted lead is 500 sg per session, and the rate of ALA.D is normalized.
Pharmacokinetics of nifedipine in patients treated by maintenance
hemodialysis (HD). H. Martre, R. Sari, E. Singlas, A. M. Taburet, and
C. Jacobs. Centre Hospitalier de Bicètre, Bicètre, and Centre Pasteur-
Vallery-Radot, Paris, France. Nifedipine, a calcium antagonist, is being
increasingly utilized for treatment of angina and/or hypertension in
uremic patients treated by HD. We report here the results of
pharmacokinetic studies of nifedipine between and during hemodialysis
sessions in patients treated by HD. The hemodialysis clearance of
nifedipine was evaluated in five patients with a residual creatinine
clearance of 1.5 0.5 mI/mn (range 0 to 3 mI/mn), who received 10 mg
of nifedipine in a fasting state 4 hrs before the start of a 4-hr
hemodialysis session performed with an open circuit dialysis system
using a 1 m2 cuprophane membrane-equipped dialyzer. Arterial and
venous blood samples were drawn 2 hrs after start of the HD session,
and the clearance of nifedipine was calculated using a formula taking
into account the patient's hematocrit and the ultrafiltration rate. Mean
blood and dialysate flows across the dialyzers were 200 mI/mn and 500
mi/mn, respectively. Plasma levels of nifedipine were determined by
gas liquid chromatography, according to the method described by
Jakobsen. The extraction ratio of nifedipine was 2.1 0.8% (range 0.2
to 4.4%), with a clearance through the dialyzer of 2.8 0.9 mi/mn
(range 0.2 to 4.9 mI/mn). This very low elimination of nidefipine by
hemodialysis can be accounted for by its liposolubility and strong
binding to plasma proteins, which, in the present study, was 90%. Ten
mg of nifedipine were administered orally on an interdialytic day to
eight fasting patients. Their residual creatinine clearance was 2.2 0.8
mi/mn (range 0 to 7 mi/mn). Blood samples were drawn at 0, 0.5, I, 1.5,
2, 4, 6, and 10 hrs after administration of the drug. Plasma half-life of
nifedipine was 2.6 0.5 hrs (range 0.7 to 4.3 hours). Peak plasma
concentration, observed 0.5 to 1 hour after administration, was 124
35 nglml (range 29 to 332). These values are comparable to those found
in patients with normal renal function, the individual variability being,
however, somewhat wider. These results can be accounted for by the
largely extrarenal elimination of nifedipine, which is metabolized up to
95% in the liver. These data indicate that the therapeutic dosage of
nifedipine does not need to be modified in patients with end-stage renal
failure treated by maintenance hemodialysis.
Rat eplthellal and mesangial glomerular cells in culture produce a
cytokine related to Interleukine one. D. Erard, D. Moulonget-Doleris, J.
Foidart, R. M. Desmottes, and P. Mahieu. INSERM U 131, Ciamart,
France, and Departement de Médecine, Université de Liege, Liege,
Belgium. We have demonstrated that rat isolated glomeruli cells disso-
ciated by enzymes produce a cytokine related to interleukine-one (IL1).
To determine the nature of the glomerular cells responsible for this
effect, we have tested purified populations of epithelial and mesangial
cells in culture. Glomeruli are isolated by enzymatic treatment and
serial sieving of cortical homogenates obtained from blood-free kid-
neys. Epithelial and mesangial cells are cultivated in RPM! 1640
supplemented with 20% fetal calf serum (FCS). From 5 to 30 days, the
culture medium is discarded, the cells are incubated for 24 hr in RPMI
+ 5% FCS, and the supernatants are kept. The IL,-like activity on the
proliferation of thymocytes with or without phytohemaglutinin is eval-
uated by 3H-thymidine incorporation. Supernatants of 5- to 8-day
epithelial cells enhance the proliferation of thymocytes with PHA (9163
cpni/2378 cpm on D5). Supernates of mesangial cells from Day 3 to 30
display a similar activity (21633 cpm13592 cpm on D5). An interleukine-
2 activity was not detected in any supernates. Like Lovett et al we have
shown that mesangial cells synthesize an 1L1-like cytokine. Moreover,
we demonstrate that epithelial cells also produce this factor.
Stimulation of lipoxygenase activity of platelets during hemodialysis.
J. B. Foidart, C. Lust, J. C. Davin, M. Saint-Remy, and P. Mahieu.
State University of Liege, Liege, Belgium. One of the most frequently
encountered side effects of hemodialysis is the generation of C3a and
C5a anaphylatoxins, which seem to play a major role in intravascular
neutrophil aggregation and neutropenia. Lipoxygenase products of
platelets (12-HETE) are also aggregating agents for neutrophils. To
evaluate the role of 12-HETE in the occurrence of dialyzer-associated
neutropenia, platelets of five patients dialyzed with cuprohane mem-
branes (group A) and of five patients dialyzed with polyacrylonitrile
membranes (group B) were purified as described by Stenson and Parker
from blood samples drawn in heparinized tubes either before initiation
of the session or 15 and 60 mm later. The 12-HETE production of
platelets was evaluated by reverse phase HPLC on a LiChrosorb RP-l8
(10 m) column after incubation of l0 cells for I hr at 37"C with I Ci
of [3H]-arachidonic acid. The following were observed: 1) the produc-
tion of 12-HETE by platelets from patients A and B was significantly
higher 15 and 60 mm after initiation of the session than at time 0; 2) the
maximum level of 12-HETE production was 2 to 3 times higher with
platelets from patients A than with platelets from patients B; 3) in
patients A only, this level was reached after IS mm and correlated
temporally with the neutropenia and complement activation; 4) in
patients A and B, plasma samples harvested after 15 and 60 mm
stimulated the 12-HETE release by the corresponding platelets isolated
at time 0; 5) the stimulation was inhibited by phenidone. The data show
that during hemodialysis: I) the lipoxygenase activity of platelets is
enhanced; 2) this enhancement is the consequence of both complement-
dependent and complement-independent mechanisms; 3) 12-HETE
may play a role in the neutropenia occurring with cuprophane mem-
branes.
Detection of significant unilateral renal artery stenosis. Interest of
iterative renal scintigraphy (hippuran) after a single dose of an angioten-
sin-converting enzyme inhibitor. J. Finaz de Villaine, M. Collard, M.
Vincent, N. Pozet, M. Labeeuw, and P. Zech. Clinique de Nephrologie
et des Maladies Metaboliques, INSERM U 80, J. Traeger, Hôpitai
Edouard Herriot, Lyon, France. Four patients with unilateral
renovascular hypertension underwent renal scintigraphy before and
after a single dose (50 mg) of an angiotensin-converting enzyme
inhibitor (ACE), captopril. Separate renal plasma flow (RPF) has been
estimated by means of renal scintigraphy with hippuran (1131) (normal
values 325 mi/mn 80 per kidney). Measurements of renal vein renin
(RVR) activity was initially performed and hypersecretion for the
stenotic kidney (SK) and suppression of renin secretion for the
controlateral kidney were assessed by the stenotic/controlateral ratio of
renal vein renin content (RSIRC): 1) For two patients, the renal vein
renin ratio was positive ( 1.5), and a decrease of RPF was observed on
the stenotic side after single dose captopril (50 mg) without any
modification of RPF on the controlateral side.
RPF, mi/mn Before After captopril
I SK
CK
217
340
62
340
2 SK
CK
108
387
31
462
The two patients had normal blood pressure after surgical therapy
(autotransplantation) in one case, and after percutaneous transluminal
angioplasty in one case. 2) For two patients, RVR ratio was negative (<
1.5) and no modification of RPF was observed, either on the stenotic K
or on the controlateral K. One patient had a thrombosis of the renal
artery with normal and symmetric RVR. The second patient presented
a stenosis involving a superior branch of the renal artery, and RVR was
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symmetric and slightly increased. Conclusion: Iterative renal
scintigraphy before and after a single dose of an ACE is a useful tool for
identifying correctable renovascular hypertension; and a decrease of
renal function of the stenotic kidney appears with ACE when patients
have lateralizing RVR.
Glomerulonephritis of SchOnlein-Henoch purpura in adults. F. de
Groc, H. Beaufils, N. Bendia, A. Baumelou, P. Godeau, J. Guedon,
and P. Lebon. Service de Nephrologie, INSERM U 27, and Service de
Médecine Interne, CHU Pitie-Salpetriere, Paris, and Service de
Néphrologie CMC Foch, Suresnes, and Service de Nephrologie, CHU
dii Mans, France. We report the clinical, laboratory, and histological
findings of 40 adult patients (29 men and 11 women) with SchOnlein-
Henoch purpura (SHP) and IgA glomerulonephritis. The mean age of
these patients was 37.1 19.2 years at the first manifestation of SHP
(50% between 16 and 30 years old). Purpura was the first clinical
manifestation of the syndrome in 34 cases (85%). Joint symptoms
occurred in 30 patients (75%), gastrointestinal involvement in 23
(57.5%), and scieritis or anterior uveitis in three. The renal disease
usually occurred in the first three months of SHP (28 patients), but
preceded the extrarenal symptoms in three patients. At the time of renal
biopsy, hematuria was constant, proteinuria was minimal (less than I
g/day) in 12 cases, and between I and 3 g/day in 13. Eleven patients had
nephrotic syndrome, eight mild renal failure (plasma creatinine less
than 200 moles/liter). Hypertension was noted in six cases. High
serum IgA levels were found in ten of 30 patients. At the skin biopsy,
there was a constant leucocytoclasic vasculitis, and vascular deposits of
IgA in only seven of the 15 cases studied. Light microscopy of kidney
biopsy specimens revealed minimal changes in one patient (2.5%), focal
and segmental glomerulonephritis in 26 (65%), diffuse proliferative
glomerulonephritis without crescents in one and with crescents in 12
(30%). IgA deposits are mesangial in 15 cases, mesangial and parietal in
22, parietal in three. Twenty-three patients were followed. One died
during the first month, of intestinal hemorrhage. Renal prognosis is
analyzed in 22 patients followed during a mean duration of 59.5 94
months. At the last examination, two patients were normal, 17 had
minor urinary abnormalities, with hypertension in six. Three patients
(13.6%) had severe (one case) or end-stage (two cases) chronic renal
failure. The presence of crescents in more than 50% of glomeruli seems
the best factor of a poor renal prognosis. In this retrospective study, it
is not possible to demonstrate any favorable effect of the therapeutic
procedures, especially corticotherapy prescribed in ten patients.
Transient defect of peripheral monocyte phagocytic function in idio-
pathic nephrotic syndrome (INS). A. Branellec, J. Laurent, J. M.
Heslan, and G. Lagnue. Service de Nephrologie, Hopital Henri
Mondor, Creteil, France. Circulating immune complexes account for a
majority of GN. Their pathogenicity depends on their size and molec-
ular composition and glomerular hemodynamic activity of phagocytes.
The phagocytic function of peripheral monocytes was studied in 15
active INS, 16 INS in complete remission, and 13 controls (INS with
minimal optical changes and negative immunofluorescence). Phagocytic
activity was assessed in vitro by phagocytic index (IP: number of
zymozan particles in each monocyte) and phagocytosis percentage (PP:
number of phagocyting monocytes).
Controls Active INS INS in remission
PP extremes 60 to 85% 31 to 67% 56 to 85%
median (79%) (47%) (73%)
IP extremes 2 to 4.38 0.89 to 2.87 1.59 to 4.15
median (3.14) (1.46) (2.99)
Differences between active INS and the two other groups are highly
significant (P < 0.001, Mann Whitney test), In six cases, phagocytic
activity, evaluated in the same patient before and after remission, was
normalized. In conclusion, alteration of monocyte phagocytic activity is
present in active INS and disappeared after complete remission. This
defect is not genetic (as suggested by Ooi), but acquired and reversible.
Its role in INS immunopathology is yet to determined.
Idiopathic nephrotic syndrome (lipoid nephrosis) and HLA DR7: DR7
prevalence is linked to age of onset. J. Laurent, J. C. Ansquer, A.
Cambon-Thomsen, C. Bracq, Ph. Reinert, and G. Lagrue. Service de
Néphrologie, Hôpital Henri Mondor, Creteil, France. High prevalence
of HLA B12 early described by Thomson was not later confirmed
(Alfiler, Dc Mouzon, O'Regan). On the other hand, high prevalence of
HLA DR7 was well documented in childhood idiopathic nephrotic
syndrome (INS). In 43 INS, child and adult patients (minimal optical
changes, with negative immunofluorescence), we found no significant
difference from control group for HLA B and DR, particularly for HLA
DR7. However, a significant difference appeared when the data were
compared in child and adult INS patients. HLA DR7 was more frequent
when the INS began before 15 years of age.
Onset before
15 years
Onset after
15 years
HLA DR7 7/14 3/29
P = 0.024, Fisher's exact test.
There was no correlation between the presence of HLA DR7 and
allergy history or increased serum IgE level, at variance with previous
data in children. Thus, the presence of DR7 would favor INS onset at
an earlier age. Alternatively, the difference in DR7 prevalence could be
an additional argument for cosidering that we classify under the same
name diseases sharing common corticosensibility and negative histo-
logical findings, but which are, in fact, different.
Decreased biological activity of serum thymic hormone (thymulin) in
children with nephrotic syndrome. A. Bensman, M. Dardenne, K.
Murnaghan, D. Vasmant, and J. F. Bach. Unite de Nephrologie
Pediatrique, Hôpita! Trousseau, INSERM U 25, Hôpital Necker,
Paris, France. The thymus gland produces a number of polypeptidic
hormones that are considered to be physiologically involved in T-cell
differentiation. One of these hormones is the serum thymic factor
(FTS), which exists in two forms: one biologically active form contains
a metal, Zn (thymulin), and one inactive form does not. Several studies
have reported that serum zinc level is decreased in childhood nephrotic
syndrome (NS). The aim of this study was first to look for a potential
Zn-dependent decrease in the biological activity of thymulin in NS, and,
second, to attempt to restore this activity by the in vitro addition of
ZnCI2. Thirty-seven children, 1 to 15 years old, with NS were studied.
Twenty-seven had a pure, primary NS, which responded to cortico-
steroid therapy. They all had normal glomerular filtration rates (GFR).
Ten children had NS secondary to chronic glomerulonephritis, three
children had a normal GFR, and six children had a decreased GFR,
three of whom had been on hemodialysis for less than 6 months at the
time of the study. Thymulin activity was measured according to the
rosette assay described previously by Dardenne and Bach. The biolog-
ical activity of thymulin was expressed as maximal active dilution of
serum. In the children with NS, the mean blood zinc level (15.6 9
mole/liter) was found to be significantly lower than that of children in
the control group (24.7 7.3 moles/liter). The thymulin levels of
children with NS were significantly lower (P < 0.001) than those of 33
normal age-matched subjects: the mean values were, respectively, 1/8
for children with NS and 1/32 for controls. There were no significant
differences among the different groups of NS patients. The serum level
of thymulin normalized after the in vitro addition of ZnCI2. This
addition of ZnCI2 did not modify the biological activity of thymulin in
control children and did not normalize it in children with an immune
deficit due to thymic anomaly. It can therefore be assumed that the
decreased biological activity of the thymic hormone noted in NS is
secondary to a low serum zinc level. These data could explain certain
anomalies of T lymphocytes described in childhood NS.
Polycythemia and renal transplant: Report of four cases. L.
Moulonguet Doléris, R. Lecave, W. Trounson, C. Dresch, and J. D.
Sraer. Service de Nephrologie, Hôpital Tenon and Service Central de
Médecine Nucléaire, Hôpital Saint Louis, Paris, France. The occur-
rence of secondary polycythemia after renal transplantation has been
frequently reported, but its cause remains unknown. In four trans-
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planted patients, it occurred between 3 and 68 months after transplan-
tation (mean, 26 months), with an average increase in red cell mass of
42%. In two cases, this necessitated frequent venesections. We elimi-
nated any cause of secondary polycythemia, either in transplanted or
nontransplanted patients. Hemopoietic stem cell activity and
erythropoietin levels were studied. Bone marrow culture examination
revealed no evidence of primary polycythemia. Two types of marrow
activity were found: I) Two patients had a normal marrow in the
number of burst-forming units (BFUe) and colony-forming units
(CFUe) derived from BFUes under the influence of lymphocytic
factors. The CFUe response to erythropoietin was normal. 2) Two
patients had abundant BFUe and CFUe, together with an exaggerated
response to exogenous erythropoietin. The mechanism of polycythemia
appeared to be different in the two groups. In the first, the total volume
of myelopoiesis may be increased, while in the second, a disturbance of
myelopoiesis is suggested. Erythropoietin activity measured in one of
the patients was low in the vein of the native kidneys, but normal from
the transplant's, and this is abnormal in the presence of secondary
polycythemia. This suggests that polycythemia following renal trans-
plantation is not explained by excessive erythropoietin and that im-
munosuppressive treatment may induce abnormal lymphocytic trans-
formation of BFUe to CFUe.
Capillary hyperpermeability with monoclonal gammapathy: In vitro
synthesis of leukotriens by leukocytes. J. D. Sraer, E. Rondeau, J. Sraer,
R. Lacave, D. Alcaix, M. Bens, L. Moulonguet Doléris, C. Mayaud.
Service de Néphrologie and Service de Pneumologie, Hôpital Tenon,
Paris, France. This syndrome, causing recurrent cardiovascular col-
lapse, is eventually fatal. Its pathogenesis is not related to inappropriate
release of histamine, vasoactive peptides, or complement components.
Inappropriate synthesis of leukotriens (LKs) is incriminated because: I)
LKs induce a capillary hyperpermeability; and 2) their action is
mediated by prostaglandins and is inhibited by indomethacin. Leuko-
cytes (L), the major source of LKs, were isolated 12 times in a patient
with the hyperpermeability syndrome and 12 times in normal subjects.
They were incubated for 10 mm at 37°C with '4C arachidonic acid (AA).
The 5-HETE (LKs precursor), the 84 LK (LTB4), the 12-20 di-HETE
(inactive metabolite of AA) were measured. The results show: 1)
nonstimulated L transform AA to 12-20 di-HETE, stimulated by
ionophore A 23187, they synthetize LTB4, while 12-20 di-HETE is no
longer detected. 2) Basal 5-HETE is higher in the patient and less
stimulated by ionophore than in the normal subjects (P < 0.01). 3) The
20 omega hydroxylase (enzyme converting 12-20 di-HETE from 20-
HETE) is directly correlated to the substrate level in normal subjects,
but not in the patient. 4) The cessation of indomethacin is associated
with a clinical relapse, a decrease of 12-20 di-HETE, and increase of
LTB4. Conclusion: 1) Ldo not synthetize LTB4 spontaneously. 2) L of
the patient are activated because basal synthesis of 5-HETE is elevated.
3) This increase in L precursor may explain the efficiency of treatment
by indomethacin. 4) lgG monoclonal role is not established.
Linear fixation of IgG along the glomerular (GBM) and tubular (TBM)
basement membranes after renal transplantation: High incidence in
Alport's syndrome. L. H. Noel, S. Querin, J. P. Grunfeld, C. Rotellar,
D. Droz, P. Mahieu, H. Kreis, and J. Berger. Département de
Néphrologie, Hôpital Necker, Paris, and Hôpital de Bavière, Liege,
Belgium. Among 767 patients (pts) who had kidney transplantation from
1959 to July, 1984, at Necker Hospital, 31 had Alport's syndrome (A).
Linear fixation of IgG along the GBM was detected in 12 pts by direct
immunofluorescence technique, on at least one renal biopsy, 3 months
to 10 years after transplantation. Five pts had Alport's syndrome,
whereas the seven others had various renal diseases (without anti-GBM
antibody). The incidence of linear fixation of LgG is, therefore, signifi-
cantly higher in transplanted pts with A (x2 test, P<0.001). Glomerular
fixation disappeared in one case and persisted in two cases on two
successive biopsies. Crescents were found in only one biopsy speci-
men. Graft survival was similar in pts with or without linear fixation.
Circulating anti-GBM antibodies were sought by indirect im-
munofluorescence (IM) (123 sera) and by radioimmunoassay (RIA) (45
sera), and were found in no cases, with or without linear fixation.
Linear fixation along the TBM was found either associated with
glomerular fixation in seven cases (including Two A) or isolated in 19
cases (including Three A). The incidence of tubular fixation was also
high in A. Circulating anti-TBM antibodies were found by IM in 12/20
cases and by RIA in 1/3 cases studied. One kidney with glomerular and
tubular linear fixation was eluted. Only anti-TBM antibodies were
detected in the eluate. In conclusion, linear fixation along the GBM
after renal transplantation is not associated with circulating anti-GBM
antibodies. In contrast, linear fixation along the TBM is frequently
accompanied by circulating anti-TBM antibodies. Both types of linear
fixation are rare, but the incidence is much higher in Alport's syndrome
than in other renal diseases. This result should be discussed with regard
to the hypothesis of the "missing GBM antigen" in A.
Changes in plasma renin activity, antidiuretic hormone, aldosterone,
and insulin with plasma exchange. M. Rainfray, A. Bussel, P. Marteau,
and R. Ardaillou. INSERM 64. Hôpital Tenon and Centre de Transfu-
sion, Hôpital Saint Louis, Paris, France. Twelve patients with a
spectrum of immunologically related disorders were studied before and
immediately after plasma exchange (PE) for changes in plasma renin
activity (PRA), aldosterone (ALD), antidiuretic hormone (ADH), and
insulin (INS). Sixteen PE were performed: five with 4% albumin in
saline and 11 with successively one-fourth 3% gelatin and three-fourths
4% albumin in saline. 126 23% (mean SD) of the plasma volume was
replaced at each PE. This corresponded to a predicted removal (R) of 74
5% for any plasma component assuming a linear relationship between
log R and the percentage exchange of plasma. The initial, final (exper-
imental), and final (predicted) concentrations (mean SD) were 2.38
0.25,0.53 0.30 and 0.61 0.62 ng/ml/hr, respectively, for PRA; 164.8
112.5,28.9 20.1, and 40.2 23 pg/mI, respectively, for ALD; 213.9
150.1, 91.0 81.7, and 55.3 40.7 pmoles/liter, respectively, for
INS; 6.4 2.5, 6.2 2.8, and 1.6 0.7 pg/liter, respectively, for ADH.
The final experimental concentrations were lower than the initial
concentrations for PRA (P < 0.01), ALD (P < 0.01), and INS (P <
0.01), but not for ADH. The predicted final concentrations were lower
than the experimental final concentrations for ADH (P < 0.001) and
INS (P = 0.05), but not for PRA and ALD. Plasma volume and plasma
osmolality did not change significantly. These results demonstrate that
the response of the releasing cells to the fall in the plasma concentration
of their secretory product does not follow the same kinetics for all
substances. Compensation was fast and nearly total for ADH, partial
for INS, whereas it did not yet occur at the end of PE for PRA and ALD
since residual concentrations of both products (22.3 and 17.5%, respec-
tively) were not significantly different from their predicted levels
(25.3%). This suggests that there is, for ADH essentially and to a lesser
degree for insulin, a fast-releasing poo1 of hormone stimulated by a
negative feedback.
Secondary oxalic lithiasis due to piridoxilate. C. Wolf, G. Maistre-
Charransol, C. Barthelemy, J. N. Ottavioli, E. Thomas, and J.
Thomas. Service de Médecine D, Hôpital Manchester, Laboratoire de
Biochimie, CHU Pitié-Salpé:riCre, Clinique Urologique, HOpital
Cochin, Paris, France. Piridoxilate (PIR) is used alone or associated
with nitrogenic compound in treatment of arterial diseases. This prod-
uct is a salt obtained from glyoxylic acid and pyridoxine. The use of
pyridoxine, theoretically, is to avoid the oxidation of glyoxylic acid to
oxalic acid. We observed 12 cases of chronic progressive oxalic lithiasis
(OL) in the case of patients treated with PIR during several years
(mean, 3.75) at 450 to 600 mg daily. Seven of them were without any
prior OL history. The lithiasis was mainly bilateral (nine cases), and
required surgery in seven cases. During the observation period, seven
patients treated with PIR presented relapses. Oxaluria (OU) level,
tested on 24 hr by gas chromatography, reached a mean of 89.6 18.3
mg (N = 27) under PIR and returned to 31.6 10.8 mg (N = 22) after
interruption of PIR treatment. Statistical z test was significant (P <
0.001). Male Wistar rats developed OL in 24 hrs after injection of 130
mg/kg of glyoxylate (equivalent to 427 mg/kg of PIR). Experimentation
on eight fasting lithiasic volunteers with injection of 200 mg of PIR
displayed an increase of OU from 3.02 1.97mg before to 12.42 2.67
mg after the injection in 3 hrs. Hence, piridoxilate appears to be a major
lithogenic factor.
"Natural killer" cell defect in alcoholic cirrhosis patients with
hepatorenal syndrome. B. Charpentier, D. Franco, and D. Fries.
Laboratoire de Transplantation d'Organes, Service de Néphrologie
and Unite de Recherches de Chirurgie Hépazique, Départemen: de
Abstracts
Chirurgie Expérimentale, Université Paris XI, Hôpital Paul Brousse,
Villejuif France. The hepatorenal syndrome represents a major index
of severity in alcoholic cirrhosis (AC). Immunological studies have
revealed a wide variety of cell-mediated immune defects, perhaps
related to increased risk of developing carcinomas. "Natural killer"
(NK) cell function was studied in 59 AC patients, of whom 20 presented
the hepatorenal syndrome and 12 patients had chronic alcoholism but
without AC. Targets were NK-sensitive cell lines K562, MOLT 4, and
NK-insensitive cell line, P815. NK cell activity was found to be low in
patients with AC, especially in patients with hepatorenal syndrome.
This was not due to modifications of the kinetics of NK activity. The
sera from AC patients had no inhibitory effect on the NK activity of
normal subjects. Lymphocytes and macrophages from AC patients did
not exert a major suppressive effect on the NK activity of normal
subjects. Interferon boosted the NK activity of cells from AC patients,
but to a lesser degree than cells from normal controls. These findings
show that a deficit of NK activity is clearly associated with AC and
more pronounced in the hepatorenal syndrome.
1,25(OH)2 Vitamin D3 assay in the hypercalciuria of sarcoidosis. A.
Meyrier, F. Paillard, R. Bouillon, and D. Valeyre. Hôpital Avicenne
Bobigny, and Hôpital Tenon, Paris, France, and Rega Institute,
Leuven, Belgium. The types of hypercalciuria and its relationship with
sarcoidosis extension and activity have rarely been investigated. We
undertook an investigation by a calcium absorption test in 39 patients
(pis) with untreated thoracic sarcoidosis. We measured serum
I ,25(OH)2D3 levels, and we sought relationships with disease extension
and activity, judged by clinical criteria and on serum angiotensin-
converting enzyme. In the whole population, seven pts (18%) had
hypercalcemia and 24 (6 1%) were hypercalciuric. The calcium absorp-
tion test disclosed three types of responses. Group! pts (N = I2) were
normocalciuric (uCa: 0.078/± 0.031 mmoles/kg/24 hr) and had normal
fasting (0.12 0.67 mmoles/mmoles, N 0.15 0.079) and post-
calcium load urinary Ca/Cr ratios (0.364 0.107, N = 0.369 0.098).
They had normal l,25(OH)2D3 serum levels (39 15 pg/mI, N = 42
13) and rare extrathoracic localizations (16.7%). The 27 hypercalciunc
pts could be divided into two groups. Group II (N = 14) had absorptive
hypercalciuria (fasting Ca/Cr: 0.19 0.069, post-load Ca/Cr: 0.84
0.27, P < 0.001). 24-hr urinary Ca (uCa) was 0.113 0.046
mmoles/kg/24 hr. Two of 14 were hypercalcemic. 1,25(OH)2D3 (P <
0.001) was high (59 14, P < 0.001). Sarcoidosis was more often
inflammatory, evolutive and disseminated (35.7%). Group III (N 13)
had resorptive hypercalciuria (fasting Ca/Cr: 0.43 0.15). They were
more hypercalciunc (uCa: 0.146 0.071 mmoles/kg/24 hr). Four of 13
were hypercalcemic. l,25(OH)2D3 was high (57 22), but to the same
degree as in Group II. Saroidosis was more disseminated (85%) and
evolutive than in Groups I and II. In the 39 patients, post-calcium load
urinary Ca/Cr and I ,25(OH)2D3 were correlated (P < 0.05). Conclusion:
1) In sarcoidosis, the type of hypercalciuria is related to the extension
of the granulomatous process; 2) absorptive hypercalciuria is explained
by excessive I ,25(OH)2D3 synthesis, presumably in granulomas; and 3)
in resorptive hypercalciuria, the mechanism of osteolysis is not solely
accounted for by high 1,25(OH)2 vitamin D3 serum levels, and we
postulate that some other factor is at work that is related to the extent
of the granulomatous process.
Hemorrhagic fever with renal syndrome (HFRS) in eastern France.
J. P. Prieur, B. Hurault de Ligny, P. E. Rollin, and M. Kessler, Service
de Néphrologie, CHU de Nancy, and Institut Pasteur, Paris, France.
Several sporadic cases of HFRS have been reported in 1983 in Belgium
and in France. Between June and November, 1983, we observed ten
cases of HFRS in the area of Nancy. It occurred in nine males and one
female (23 to 51 years). The onset was abrupt, with severe influenza-like
syndrome, intense abdominal and lumbar pain, proteinuna (six cases
out of ten), and acute renal failure. Eight patients were oliguric, and
three presented an acute myopia. A decrease in platelet count was
noted in three cases and hemorrhagic clinical features (hematuria,
purpura, melena, epistaxis, conjunctival hyperhemia) occurred in six
patients. In six cases, renal biopsy revealed acute interstitial nephritis
with edema and congestion in the medulla. No dialysis was necessary,
and recovery was complete in all cases. HFRS serologies (strains 76 to
118 and Puumala) showed significantly increased antibodies. None of
these patients had travelled out of northeastern France during the 2
693
months preceding the disease. A seroepidemiologic survey is now in
progress in this area. Antibodies to HFRS virus were detected in sera of
six (2.45%) of 244 persons (dialyzed, kidney transplant recipients,
out-patients) in the Nephrology Department. These observations and
the first results of this epidemiological inquiry attest to the occurrence
of HFRS in the East of France. They also confirm the existence of mild
and even asymptomatic clinical forms preventing diagnosis and exact
evaluation of the regional incidence of HFRS.
Specific binding of (3H)-piretanide to membranes of renal medulla.
E. M. Giesen-Crouse, J. L. Imbs, C. Welsch, andJ. Schwartz. Institut
de Pharmacologie, INSERM U 206, Faculté de Médecine, S:rasbourg,
France. The site of action of 1oop diuretics of the benzoic acid family,
such as furosemide and piretanide, is the TAHL where they inhibit the
Na, K, and C1 cotransport. The subcellular mechanism of action of
these compounds is, however, unknown. Here we demonstrate the
existence of two independent receptors on plasma membranes from
renal medulla of the dog. They display all the characteristics of a
specific receptor, such as specific, saturable, and reversible binding of
(3H)-piretanide (30 Ci'mmole). The two receptors differ in affinity for
piretanide: one has a Kd of 10 flM, the other of 200 nM. Bumetanide,
furosemide, and their derivatives displace (3H)-piretanide; nondiuretic
analogues and diuretics with a different mode of action (thiazides and
derivates, amiloride) do not. The order of affinity is parallel to the order
of diuretic potency. (3H)-piretanide does not bind specifically to spleen
or liver membranes. It is possible that one (or both) receptors are
related to the Na, K, and Cl cotransport system because the
presence of all three ions is necessary both for optimal transport and for
optimal binding. High Na and C1 (128 mM) but not high K* concen-
trations lead to a decrease of affinity of the high affinity receptor. The
low affinity receptor is sensitive to high concentrations of all three ions.
Contribution of computerized tomography (CT) to the clinical knowl-
edge of acute pyelonephritis (APN). Evaluation of 48 cases. B. Ody and
M. Leski. Département de Radiologie and Division de Néphrologie,
Hópital Cantonal Universitaire, Geneva, Switzerland. The aim of this
work was to define the role of CT in the evaluation of aspects,
extension, severity, and evolution of APN lesions. The examination
was performed with a third generation CT (Somatom Siemens, slice
thickness: 8mm, acquisition time: 5 sec) and included plain slices
followed by bolus injection of contrast medium, with immediate and/or
delayed slices (until 10 hrs). Forty-eight patients (mean: 39 17 years
old) were examined over 3 years; among them, 19 were examined from
10 days to 18 months (a total of 72 scans). Results: CT signs (hypodense
nodular or edge-shaped lesions, surrounded by contrast in delayed
slices, of either focal or global renal distribution) were present in 57% of
observed APN episodes. The kidneys were normal on CT in 23%, but
abscesses were observed in 10%. There is no significant correlation
between CT findings and one of the following signs: positive blood
cultures, chill, acute renal failure, urinary tract abnormalities or recur-
rences of APN. In ten out of II patients, short-term examinations
revealed persistent or incomplete regression of the lesions, whereas
APN was clinically cured. Long-term examinations (ten patients)
showed scarring in six patients, two without risk factor. Conclusions:
The imaging of APN by CT is valuable, sometimes with radioclinical
discrepancies (abscess without clinical signs, persistent CT positivity
after clinical cure, normal renal CT appearance of some APN). CT
demonstrates scars not visible by other techniques and can aid the
evaluation of the appropriate duration of antibiotherapy.
Psychological aspects of continuous ambulatory peritoneal dialysis(CAPD). M. de Massougnes, A. Gunn-Sechehaye and M. Leski.
Division de Psychiatrie et Psychologie Médicale, Division de
Néphrologie, Hôpital Cantonal Universitaire, Geneva, Switzerland.
The aim of this study is to evaluate the psychological aspects of CAPD.
Data were obtained from IS patients who had been treated by CAPD (13
men and two women) by means of two interviews of I hr each. At the
time of the study, seven patients were on CAPD, six had been
transplanted, and two were on hemodialysis. Ages ranged from 30 to 63
years (mean, 47 years). The mean duration of treatment was 21 months
(2 to 48 months). Seven of the patients had never experienced
hemodialysis. Results: Thirteen patients (regardless of sex and age)
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showed positive psychological reaction to CAPD; they reported a
feeling of well-being and appreciated the absence of food and liquid
restrictions, and satisfactorily adapted the method to familial and
professional requirements, as well as to leisure. CAPD allows an
independence which contributes to the maintenance and the improve-
ment of self-esteem; this point is stressed by patients who had prior
experience with hemodialysis. On the other hand, sex and age do
intervene as far as negative reactions are concerned; women and young
patients have been shown to be particularly sensitive. These patients
emphasize the importance of a stable marital relationship, which helps
to express their feelings. A constant worry about infection and
sequellea, especially as occurrences are frequent, nurtures a permanent
state of anxiety. Conclusion: The explanation of the good psychological
acceptance of this method and its favorable somatic results have to be
related to recovered body function and the making of a new kidney
(neither machine nor graft) that belongs to the patient. The degree of
risk attributed to the method is the same as in transplantation.
Non-dilated obstructive acute renal failure. M. Laville, P. J. Maillet,
D. Pelle-Francoz, J. Finaz de Villaine, J. Traeger, and A. Pinet.
Clinique de Nephrologie et Maladies Metaboliques et Service
d'Uroradiologie, Hôpi:al Edouard-Herriot, Lyon, France. Renal
sonography has gained a wide acceptance for the diagnosis of acute
renal failure (ARF), since it detects either chronic renal failure with
renal atrophy or obstructive ARF with dilated pyelocalyceal system.
Repeated examinations among 74 patients with obstructive ARF, 70 of
whom had obviously dilated cavities on sonography, failed to show any
dilation in four patients, without evidence for prerenal or renal ARF.
After durations of anuria, 3, 5, 7, and 34 days, respectively, the
presence of a urinary obstruction, its nature and localization, was
demonstrated by percutaneous antegrade pyelography (PAP): two uric
acid calculi, one edema of the ureter, and one bladder carcinoma. PAP
was followed by a percutaneous nephrostomy, which permitted an
immediate diuresis in the four patients. Recovery was obtained in three
patients by percutaneous methods only. These four cases suggest that
non-dilated urinary cavities can be observed, even in the presence of a
complete obstruction. In such settings, the proof of urinary obstruction
is provided only by direct opacification of the cavities, which is best
performed by PAP. Moreover, PAP is often the first step toward a
percutaneous urinary diversion.
Characterization of monodonal antibodies (Mab) against human
Tamm-Horsfall protein (THP). P. Ronco, M. Geniteau, P. Verroust, G.
Richei, and M. Brunisholz. INSERM U 64, Hop/ta! Tenon, Paris,
France. THP, a glycoprotein produced by cells from the thick ascend-
ing limb of the loop of Henle, is the most abundant protein in normal
urine and a major component of all casts. Its function, extrarenal
distribution, and measurement remain imprecise, mainly because of the
lack of specificity of the available immunological reagents. This
prompted us to produce specific Mab. Although THP used for immu-
nization had been highly purified, IS clones reactive with non-THP
tubular antigens were detected by indirect immunofluorescence (IF) on
cryostat kidney sections. Fifteen anti-THP Mab were identified by
indirect IF and immunoenzyme assay (lEA) using solid phase THP.
Binding inhibition studies demonstrated that the 15 Mab were specific
for seven different epitopes. We were able to use this antibody diversity
to develop a sensitive "sandwich lEA", using two Mab with distinct
specificities. This assay allowed the reproducible measurement of 5
ng/ml THP. It was used to demonstrate the presence in serum of
immunoreactive material sharing with urinary THP in five of the seven
epitopes (two were not analyzed) and co-migrating with the latter on
SDS polyacrylamide gel electrophoresis. Finally, using Mab coupled to
Sepharose 4 B, large amounts of THP could be purified in one step from
human urine. Anti-THP Mab seem to be promising tools for further
studies of the physiological properties and distribution of this protein.
Ultrafiltration pump-assisted continuous arteriovenous hemofiltration
(CAVH): Experience with a highly permeable plate hemofliter. T. Mi!-
cent, 0. Toupance, S. Lavaud, H. Roujouleh, A. Wynckel, J. P. Me/in,
andJ. Chanard. Service de Néphrologie, CHU Reims, Reims, France.
Continous artenovenous hemofiltration (CAVH) requires constant su-
pervision and frequent readjustment of the rate of infusion of the
substitution fluid because of variable filtration rate. To lighten the
burden of the management of patients treated with CAVH, an ultrafil-
tration pump-assisted CAVH was tested, first in the dog, then in 16
patients with oliguric renal failure and cardiovascular instability treated
in the intensive care unit. A plate hemofilter (Biospal) was used, which
is equipped with the high hydraulic permeability AN 69 S membrane (in
vitro filtration rate: 23 mi/hr/mm Hg; surface area: 0.5 m2; priming
volume: 60 ml). The driving pump was set in order to modulate the
ultrafiltration rate from 400 to 1000 mi/hr. Ultrafiltration pump-assisted
CAVH was given for 8.1 5.3 days, and the filtration volume was i6.3
3.1 liters/day. The mean life span of the hemofilter was 46.4 27.3
hrs. No adverse reaction toward the artificial membrane was detected.
Adequate control of fluid balance and electrolyte and acid-base
homeostasis were obtained, allowing hypercaloric parenteral nutrition.
However, in two instances, additional hemodiaiysis was required to
adequately control urea generation. Death occurred in nine cases.
Ultrafiltration pump-assisted CAVH proved to be a simple and effective
method of fluid removal and urea extraction by convective transport.
Maintenace of stable fluid balance and optimal hypercaloric parenteral
nutrition were achieved.
